Claims for Patent: 4,824,860

Summary for Patent: 4,824,860

Title:	Treatment of Parkinsons disease
Abstract:	The present invention relates to the use of certain indolone derivatives in particular, 4-(2-di-n-propyl-aminoethyl)-2-(3H)-indolone in a method of treatment of Parkinsons disease.
Inventor(s):	Owen; David A. A. (Welwyn Garden City, GB2)
Assignee:	Smith Kline & French Laboratories Limited (Welwyn Garden City, GB2)
Application Number:	07/196,653
Patent Claims:	1. A method of treatment of Parkinsons Disease which comprises administering an effective non-toxic amount for the treatment of Parkinsons Disease of a compound of the following structure: ##STR2## in which each group R is hydrogen or C.sub.1-4 alkyl; R.sup.1 and R.sup.2 are each hydrogen or C.sub.1-4 alkyl; R.sup.3 is hydrogen or hydroxy; and n is 1 to 3; or a pharmaceutically acceptable salt thereof to a subject in need thereof. 2. A method of treatment of Parkinsons Disease which comprises administering an effective non-toxic amount for the treatment of Parkinsons Disease of 4-(2-di-n-propylaminoethyl)-2-(3H)-indolone to a subject in need thereof. 3. A method of treatment of Parkinsons Disease which comprises administering an effective non-toxic amount for the treatment of Parkinsons Disease of 4-(2-di-n-propylaminoethyl)-2-(3H)-indolone hydrochloride to a subject in need thereof.